文献速递神经创伤神经重症

超低频压力反应性指数在儿童创伤性脑损伤患者中的评估与应用

Evaluation and application of ultra-low-frequency pressure reactivity index in pediatric traumatic brain injury patients.
PubMed 文献 · Acta Neurochir (Wien) · 2023-02-27

本研究回顾性纳入47例需颅内压监测的0-18岁创伤性脑损伤患者,评估基于约5分钟采样数据的超低频压力反应性指数(UL-PRx)。UL-PRx均值0.30可区分6个月生存与死亡(AUC 0.90)及有利与不利结局(AUC 0.70)。多因素分析中,平均UL-PRx和颅内压>20 mmHg时间百分比与6个月死亡率和不利结局显著相关,即使校正IMPACT-Core变量后仍显著。

要点

  • UL-PRx均值0.30为区分6个月生存与死亡(AUC 0.90)及有利与不利结局(AUC 0.70)的阈值。
  • 平均UL-PRx和颅内压>20 mmHg时间百分比与6个月死亡率和不利结局显著相关,校正IMPACT-Core后仍显著。
  • 6例二次去骨瓣减压术患者术后UL-PRx无显著变化。

核心结论

  • UL-PRx与6个月结局相关,即使校正IMPACT-Core变量后仍相关。
  • 其在儿科重症监护中的应用可能有助于评估脑自动调节,并为儿童创伤性脑损伤患者提供可能的预后和治疗意义。

研究设计与样本

  • 回顾性收集0-18岁需颅内压监测的儿童创伤性脑损伤患者数据,使用MATLAB和自研算法处理。
  • 共纳入47例儿童创伤性脑损伤患者。

主要发现

  • UL-PRx均值、颅内压、脑灌注压及衍生指数与6个月死亡率和不利结局显著相关。
  • UL-PRx值0.30被确定为区分生存与死亡患者(AUC 0.90)及有利与不利结局(AUC 0.70)的阈值。
  • 多因素分析中,平均UL-PRx和颅内压>20 mmHg时间百分比与6个月死亡率和不利结局显著相关,即使校正IMPACT-Core变量后仍显著。
  • 6例接受二次去骨瓣减压术的患者术后UL-PRx无显著变化。

关键数值与推荐

  • UL-PRx阈值0.30用于区分6个月生存与死亡(AUC 0.90)及有利与不利结局(AUC 0.70)。

临床怎么用

  • UL-PRx在儿科重症监护中的应用可能有助于评估脑自动调节,并为儿童创伤性脑损伤患者提供可能的预后和治疗意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: While clinical practice suggests that knowing the cerebral autoregulation (CA) status of traumatic brain injury (TBI) patients is crucial in assessing the best treatment, evidence in pediatric TBI (pTBI) is limited. The pressure reactivity index (PRx) is a surrogate method for the continuous estimation of CA in adults; however, calculations require continuous, high-resolution monitoring data. We evaluate an ultra-low-frequency pressure reactivity index (UL-PRx), based on data sampled at ∼5-min periods, and test its association with 6-month mortality and unfavorable outcome in a cohort of pTBI patients. METHODS: Data derived from pTBI patients (0-18 years) requiring intracranial pressure (ICP) monitoring were retrospectively collected and processed in MATLAB using an in-house algorithm. RESULTS: Data on 47 pTBI patients were included. UL-PRx mean values, ICP, cerebral perfusion pressure (CPP), and derived indices showed significant association with 6-month mortality and unfavorable outcome. A value of UL-PRx of 0.30 was identified as the threshold to better discriminate both surviving vs deceased patients (AUC: 0.90), and favorable vs unfavorable outcomes (AUC: 0.70) at 6 months. At multivariate analysis, mean UL-PRx and % time with ICP > 20 mmHg, remained significantly associated with 6-month mortality and unfavorable outcome, even when adjusted for International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT)-Core variables. In six patients undergoing secondary decompressive craniectomy, no significant changes in UL-PRx were found after surgery. CONCLUSIONS: UL-PRx is associated with a 6-month outcome even if adjusted for IMPACT-Core. Its application in pediatric intensive care unit could be useful to evaluate CA and offer possible prognostic and therapeutic implications in pTBI patients. CLINICALTRIALS: GOV: NCT05043545, September 14, 2021, retrospectively registered.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Gritti P, Bonfanti M, Zangari R, et al. Evaluation and application of ultra-low-frequency pressure reactivity index in pediatric traumatic brain injury patients. Acta Neurochir (Wien). 2023. PMID: 36847979. doi:10.1007/s00701-023-05538-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。